Other
Coagulation
0
Pipeline Programs↗
2
Active Trials↗
7
Companies Involved↗
Coagulation is an early-stage landscape with 0 programs across 7 companies. The most active players are Boehringer Ingelheim, vTv Therapeutics, Melinta Therapeutics, Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
32
clinical trials
Completed20 · 63%
Unknown status7 · 22%
Terminated3 · 9%
Recruiting2 · 6%
Clinical Trials
Trial Activity
32 trials
Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein
Recruiting·—·Phase 3·NCT06142552·120 enrolled
A Study of Repeat Dosing of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection
Completed·—·Phase 2·NCT05265286·15 enrolled
Comparison of Rapid Thrombelastography and Conventional Coagulation Testing for Haemostatic Resuscitation in Trauma
Completed·—·N/A·NCT01536496·114 enrolled
Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for ME Secondary to BRVO
Completed·—·N/A·NCT03054766·80 enrolled
A Study to Evaluate the Safety and Pharmacokinetic of Recombinant Human Coagulation Factor VIII ，Fc Fusion Protein for Injection
Completed·—·Phase 1·NCT05251090·13 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)